SCHEMBL6894465

SCHEMBL6894465

CC(C)C(I)OC(=O)Oc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 2/20 0.40
ELANE P08246 2/20 0.40
MAPT P10636 1/20 0.40
CYP2D6 P10635 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
MTNR1A P48039 4/20 0.39
MTNR1B P49286 4/20 0.39
USP2 O75604 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
ALOX15 P16050 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895672 0.85 ALDH1A1 (0.42) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL1792881 0.81 TSHR (0.48) ATML3MBTL1ALDH1A1ELANEMAPT
Benzene SCHEMBL8717860 0.81 TSHR (0.48) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL14040359 0.79 ATM (0.44) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL4492405 0.78 ALOX15 (0.43) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL16353853 0.78 ALDH1A1 (0.42) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL9464671 0.78 ALDH1A1 (0.42) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL4740194 0.78 ALDH1A1 (0.42) ATML3MBTL1ALDH1A1ELANEMAPT
SCHEMBL2235343 0.78 HTR2A (0.52) ALDH1A1MAPTMEN1LMNATP53
SCHEMBL6895252 0.77 ALDH1A1 (0.42) ATML3MBTL1ALDH1A1ELANEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677331-B2 HAVING SUBSTITUTED IMIDAZO(5,1-B)THIAZOLE GROUP AT 2-POSITION; MICROBIOCIDES AGAINST BETA-LACTAMASE PRODUCING BACTERIA AND RESISTANT PSEUDOMONAS MEIJI SEIKA KAISHA, LTD. (JP) 2004-01-13 US disclosed
US-20030149016-A1 Novel carbapenem derivatives KANO YUKO (JP) 2003-08-07 US disclosed
US-6458780-B1 IMIDAZO(5,1-B)THIAZOLE GROUP AT THE 2-POSITION ON THE CARBAPENEM RING HAVE HIGH ANTI-MICROBIAL ACTIVITIES AGAINST .BETA.-LACTAMASE PRODUCING BACTERIA, MRSA, RESISTANT-PSEUDOMONAS AERUGINOSA, PRSP, ENTEROCOCCI, AND MEIJI SEIKA KAISHA, LTD. (JP) 2002-10-01 US disclosed
EP-1101766-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2001-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149016-A1 Novel carbapenem derivatives DPEP1, TMPRSS15, STK35 ATM 4611/4885L3MBTL1 2671/4885ALDH1A1 1161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.